CS2 Decoy Targets Parkinsons Mitochondrial Breakdown

CWRU researchers link alpha-synuclein to mitochondrial dysfunction in Parkinsons by binding to the ClpP enzyme; they designed a CS2 decoy to block this interaction, reducing inflammation and restoring function in cells and animal models, offering a potential root-cause therapy with human trials possible in about five years.